BRPI0919629A2 - Método para preparação da (3s,4s)-4-(r-2-(benziloxi) tridecil) - 3 - hexil -2- oxetanona e novos intermediários utilizados - Google Patents

Método para preparação da (3s,4s)-4-(r-2-(benziloxi) tridecil) - 3 - hexil -2- oxetanona e novos intermediários utilizados

Info

Publication number
BRPI0919629A2
BRPI0919629A2 BRPI0919629-3A BRPI0919629A BRPI0919629A2 BR PI0919629 A2 BRPI0919629 A2 BR PI0919629A2 BR PI0919629 A BRPI0919629 A BR PI0919629A BR PI0919629 A2 BRPI0919629 A2 BR PI0919629A2
Authority
BR
Brazil
Prior art keywords
oxetanone
tridecyl
benzyloxy
hexyl
preparation
Prior art date
Application number
BRPI0919629-3A
Other languages
English (en)
Inventor
Sang Min Yun
Dong Jin Hong
Weon Ki Yang
Jae Ho Yoo
Ji Sook Kim
Moon Sub Lee
Han Kyong Kim
Eun Jung Lim
Young Ho Moon
Young-Kil Chang
Gwan Sun Lee
Original Assignee
Hanmi Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Holdings Co Ltd filed Critical Hanmi Holdings Co Ltd
Publication of BRPI0919629A2 publication Critical patent/BRPI0919629A2/pt
Publication of BRPI0919629A8 publication Critical patent/BRPI0919629A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
BRPI0919629A 2008-11-04 2009-10-30 Método para preparação da (3s,4s)-4-(r-2-(benziloxi) tridecil) - 3 - hexil -2- oxetanona e novos intermediários utilizados BRPI0919629A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080108991A KR101126084B1 (ko) 2008-11-04 2008-11-04 (3ｓ,4ｓ)-4-((ｒ)-2-(벤질옥시)트라이데실)-3-헥실-2-옥세타논의 제조방법 및 이에 사용되는 중간체
PCT/KR2009/006338 WO2010053275A2 (en) 2008-11-04 2009-10-30 Method for preparing (3s,4s)-4-((r)-2-(benzyloxy)tridecyl)-3-hexyl-2-oxetanone and novel intermediate used therefor

Publications (2)

Publication Number Publication Date
BRPI0919629A2 true BRPI0919629A2 (pt) 2015-08-18
BRPI0919629A8 BRPI0919629A8 (pt) 2016-06-07

Family

ID=42153375

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919629A BRPI0919629A8 (pt) 2008-11-04 2009-10-30 Método para preparação da (3s,4s)-4-(r-2-(benziloxi) tridecil) - 3 - hexil -2- oxetanona e novos intermediários utilizados

Country Status (14)

Country Link
US (1) US8637700B2 (pt)
EP (1) EP2376469B1 (pt)
JP (1) JP5301676B2 (pt)
KR (1) KR101126084B1 (pt)
CN (1) CN102177149A (pt)
AU (1) AU2009311846B2 (pt)
BR (1) BRPI0919629A8 (pt)
CA (1) CA2741690C (pt)
ES (1) ES2467677T3 (pt)
IL (1) IL212632A (pt)
MX (1) MX2011004657A (pt)
NZ (1) NZ591735A (pt)
TW (1) TWI383974B (pt)
WO (1) WO2010053275A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2389370A4 (en) * 2009-01-22 2012-09-05 Biocon Ltd CRYSTALLINE FORM OF ORLISTAT AND METHOD THEREFOR
CN112625009A (zh) * 2020-12-18 2021-04-09 植恩生物技术股份有限公司 一种奥利司他关键中间体的精制方法
CN114702383B (zh) * 2022-03-24 2024-03-15 中山万汉制药有限公司 一种苄氧基取代的脂肪酸衍生物及其制备方法与用途
CN115403464A (zh) * 2022-08-01 2022-11-29 湖南迪诺制药股份有限公司 奥利司他中间体、其制备方法及奥利司他合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3918364A1 (de) * 1989-06-06 1990-12-13 Hoechst Ag 3-desmethyl-2-methyl-mevalonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US6545165B1 (en) * 2000-02-04 2003-04-08 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
US6392061B1 (en) * 2000-10-16 2002-05-21 Zpro Chemical, Inc. Process for making (2S, 3S, 5S) oxetanone derivatives
US6734177B2 (en) * 2001-04-17 2004-05-11 Novartis Ag Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
PL367885A1 (en) * 2001-06-13 2005-03-07 Ranbaxy Laboratories Limited Methyl analogs of simvastatin as novel hmg-coa reductase inhibitors
JPWO2004065346A1 (ja) 2003-01-21 2006-05-18 住友化学株式会社 （−）−テトラヒドロリプスタチンおよびその中間体の製造方法

Also Published As

Publication number Publication date
ES2467677T3 (es) 2014-06-12
EP2376469B1 (en) 2014-04-30
CA2741690A1 (en) 2010-05-14
NZ591735A (en) 2012-03-30
EP2376469A4 (en) 2012-05-02
JP5301676B2 (ja) 2013-09-25
KR20100049941A (ko) 2010-05-13
CN102177149A (zh) 2011-09-07
RU2011122677A (ru) 2012-12-20
WO2010053275A2 (en) 2010-05-14
IL212632A (en) 2014-12-31
US20110178330A1 (en) 2011-07-21
AU2009311846B2 (en) 2011-11-10
TW201024273A (en) 2010-07-01
TWI383974B (zh) 2013-02-01
CA2741690C (en) 2013-11-19
BRPI0919629A8 (pt) 2016-06-07
US8637700B2 (en) 2014-01-28
WO2010053275A3 (en) 2010-08-19
EP2376469A2 (en) 2011-10-19
AU2009311846A1 (en) 2011-06-30
JP2012507506A (ja) 2012-03-29
IL212632A0 (en) 2011-07-31
KR101126084B1 (ko) 2012-03-29
MX2011004657A (es) 2011-05-30

Similar Documents

Publication Publication Date Title
BRPI0816694A2 (pt) Processo e intermediários para preparação d einibidores de integrase
ATE535282T1 (de) Benzoazepin-oxy-essigsäurederivate als ppar-delta-agonisten zur erhöhung von hdl-c, senkung von ldl-c sowie cholesterinsenkung
BRPI0815387A2 (pt) composição farmacêutica, método para fazer uma composição farmacêutica e método de tratar uma condição
BRPI0922475A2 (pt) composto, composição farmacêutica , método para tratar câncer, e, uso de um composto.
BRPI0911685A2 (pt) composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit
BRPI0716752A2 (pt) processo e intermediÁrios para preparo de inibidores de intergrase
BRPI0906786A2 (pt) Composto, processo para a preparação de um composto, uso de um composto, método para o tratamento de uma doença ou condição, composição farmacêutica, processo para a preparação de uma composição farmacêutica, produto, e, kit.
BRPI0916082A2 (pt) método para formação de um diodo emissor de luz convertido com fósforo (pc - led), diodo emissor de luz convertido com fósforo (pc - led), e, estrutura intermediária de diodo emissor de luz (led)
BRPI0924622A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso.
BRPI0914343A2 (pt) composição, produto, uso da composição e método
DK3428148T3 (da) Aryloazol-2-yl-cyanoethylaminoforbindelser, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf
BRPI0913585A2 (pt) composto, método para fabricar um composto, composição farmacêutica, uso de um composto, e, método para o tratamento ou prevenção de distúrbios
DK2019090T3 (da) Substitueret beta-phenyl-alfa-hydroxypropansyre, fremgangsmåde til syntese og anvendelse deraf
BRPI0907977A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BR112012020585A2 (pt) composto, composição farmacêutica e método de tratamento de um distúrbio mediado por tirosina quinase
BRPI0907974A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
CL2009001298A1 (es) Compuestos derivados de n-ciclohexil-2-fenoxinicotinamida; composición farmcéutica que los comprende; combinación farmacéutica que los comprende; y su uso para tratar una enfermedad mediada por la pde4.
BRPI0914371A2 (pt) "composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"
BRPI0817721A2 (pt) Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto
DK2307445T3 (da) Fremgangsmåde til fremstilling af caspofungin og mellemforbindelser heraf
BRPI0908883A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0923856A2 (pt) composto, composição farmacêutica, uso de um composto, e método para tratar uma doença ou distúrbio.
BRPI1007654A2 (pt) composto, processo para a obtenção de um composto de fórmula geral e composição farmacêutica
DK2274245T3 (da) Fytosystem, dets anvendelse og fremgangsmåde til behandling af spildevand
BRPI0920933A2 (pt) molécula de ácido nucleico de dupla fita, composição farmacêutica, e, método para tratar um indivíduo humano sofrendo de uma condição

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: HANMI SCIENCE CO., LTD. (KR)

B25G Requested change of headquarter approved

Owner name: HANMI SCIENCE CO., LTD. (KR)

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements